市場調査レポート

商品コード

欧州の神経刺激装置：2030年市場予測-地域別分析-製品、用途、エンドユーザー別

Europe Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

出版日: 2024年04月05日 | 発行: The Insight Partners

| ページ情報: 英文 91 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,550 513,081円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,550 657,611円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,550 802,141円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.53円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

欧州の神経刺激装置市場は、2022年に17億1,784万米ドルと評価され、2030年には34億5,924万米ドルに達すると予測され、2022年から2030年までのCAGRは9.1%と推定されます。

脊髄損傷患者の増加が欧州の神経刺激装置市場を牽引

神経刺激装置産業は、さまざまな脊髄障害を起こしやすい高齢者人口の増加によって牽引力を増しています。これらの人口は、変性椎間板疾患、変形性関節症、脊柱側弯症、脊椎腫瘍、脊柱管狭窄症などの脊椎疾患を発症しやすくなっています。高齢化が進むにつれ、脊椎の自然な磨耗や損傷は、いくつかの脊椎疾患を引き起こす可能性があります。それゆえ、高齢化社会は、虚弱、内科的合併症、栄養状態の低下、術後合併症の発生確率の高さなどの理由から、脊椎外科医に独特の課題を突きつけています。2022年10月に発表された世界保健機関（WHO）のデータによると、2050年までに高齢者人口の約80％が低・中所得国に住むようになり、この高齢化のペースは過去よりもはるかに速くなると予想されています。人口動態の高齢化は、生活習慣に関連する要因と相まって、椎間板変性疾患や脊柱変形などの脊椎の問題を経験する個人の大幅な増加につながっています。そのため、高齢者や成人における脊髄損傷の発生率が高く、神経刺激装置の需要を刺激しています。

欧州の神経刺激装置市場概要

欧州の神経刺激装置市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。この地域の市場は、脳動脈瘤、脳卒中などの神経疾患の有病率の上昇と、この地域で事業を展開する市場参入企業による製品革新の増加により、今後数年間で大きく成長すると予想されます。市場の成長はまた、ドイツ、フランス、スペインなどの国々におけるヘルスケアシステムの開拓と、地域の主要企業による革新的な製品発売の増加にも起因しています。2020年6月、Medtronic社はBrainsenseTM技術を搭載したPerceptTM PC神経刺激装置の発売を発表しました。この技術は、パーキンソン病（PD）の症状を和らげるために、脳への電気刺激を同時に記録・供給します。

欧州の神経刺激装置市場の収益と2030年までの予測（金額）

欧州の神経刺激装置市場セグメンテーション

欧州の神経刺激装置市場は、製品、用途、エンドユーザー、国によって区分されます。

製品別では、欧州の神経刺激装置市場は脊髄刺激装置、脳深部刺激装置、仙骨神経刺激装置、迷走神経刺激装置、その他に区分されます。脊髄刺激装置セグメントは2022年に最大の市場シェアを占めました。

用途別では、欧州の神経刺激装置市場は疼痛管理、てんかん、尿失禁・便失禁、パーキンソン病、その他に分類されます。疼痛管理分野が2022年に最大の市場シェアを占めました。

エンドユーザー別では、欧州の神経刺激装置市場は病院、専門クリニック、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、欧州の神経刺激装置市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。ドイツが2022年の欧州の神経刺激装置市場シェアを独占。

Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、ElectroCore Inc、Mainstay Medicalは、欧州の神経刺激装置市場で事業を展開している大手企業の一部です。

List Of Tables

Table 1. Neurostimulation Devices Market Segmentation
Table 2. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 11. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 12. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 15. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country
Figure 2. Neurostimulation Devices Market: Key Industry Dynamics
Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. Europe Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
Figure 22. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
Figure 23. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Product Code: BMIRE00030035

The Europe neurostimulation devices market was valued at US$ 1,717.84 million in 2022 and is expected to reach US$ 3,459.24 million by 2030; it is estimated to register a CAGR of 9.1% from 2022 to 2030.

Rising Cases of Spinal Cord Injury Fuel Europe Neurostimulation Devices Market

The neurostimulation devices industry has gained traction owing to the rising elderly population prone to various spinal disorders. These population is becoming more susceptible to developing spinal disorders such as degenerative disc diseases, osteoarthritis, scoliosis, spinal tumor, and spinal stenosis. As this population ages, the natural wear and tear of the spine can lead to several spinal disorders. Hence, with this fact, the aging population poses a unique challenge to spine surgeons due to multiple increased frailty, medical comorbidities, decreased nutritional status, and the higher probability of postoperative complications. According to the World Health Organization (WHO) data published in October 2022, approximately 80% of the elderly population will be living in low-and middle-income countries by 2050, and it is anticipated that the pace of this population aging will be much faster than in the past. The aging demographic, coupled with lifestyle-related factors has led to a substantial increase in individuals experiencing spinal issues such as degenerative disc disease and spinal deformities. Therefore, high incidence of spinal cord injuries in old age and adults stimulates the demand for neurostimulation devices.

Europe Neurostimulation Devices Market Overview

The Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. The regional market is expected to grow significantly in the coming years owing to the rising prevalence of neurologic disorders such as cerebral aneurysms, stroke, and others and increasing product innovations made by the market players operating in the region. The market growth is also attributed to the development of healthcare systems in countries such as Germany, France, and Spain and rise in innovative product launches by key regional companies. In June 2020, Medtronic announced the launch of the PerceptTM PC Neurostimulator with BrainsenseTM technology. The technology simultaneously records and delivers electrical stimulations to the brain to relieve symptoms of Parkinson's disease (PD).

Europe Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Neurostimulation Devices Market Segmentation

The Europe neurostimulation devices market is segmented based on product, application, end user, and country.

Based on product, the Europe neurostimulation devices market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held the largest market share in 2022.

In terms of application, the Europe neurostimulation devices market is categorized into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held the largest market share in 2022.

By end user, the Europe neurostimulation devices market is segmented into hospitals, specialty clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe neurostimulation devices market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe neurostimulation devices market share in 2022.

Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc, Synapse Biomedical Inc, ElectroCore Inc, and Mainstay Medical are some of the leading companies operating in the Europe neurostimulation devices market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Neurological Disorders
- 4.1.2 Rising Cases of Spinal Cord Injury
4.2 Market Restraints
- 4.2.1 Lack of Expert Professionals
4.3 Market Opportunities
- 4.3.1 Growing Advances and Approvals for Neurostimulation Devices
4.4 Future Trends
- 4.4.1 Rising Demand for Noninvasive Treatment
4.5 Impact Analysis

5. Neurostimulation Devices Market - Europe Market Analysis

5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Spinal Cord Stimulator
- 6.3.1 Overview
- 6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Deep Brain Stimulator
- 6.4.1 Overview
- 6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Sacral Nerve Stimulator
- 6.5.1 Overview
- 6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vagus Nerve Stimulator
- 6.6.1 Overview
- 6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Pain Management
- 7.3.1 Overview
- 7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Epilepsy
- 7.4.1 Overview
- 7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Urinary and Fecal Incontinence
- 7.5.1 Overview
- 7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Parkinson's Disease
- 7.6.1 Overview
- 7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Specialty Clinics
- 8.4.1 Overview
- 8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Europe: Neurostimulation Devices Market
- 9.1.1 Overview
- 9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  - 9.1.2.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  - 9.1.2.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
  - 9.1.2.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
    - 9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
    - 9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Boston Scientific Corp
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nevro Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 LivaNova Plc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Synapse Biomedical Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 ElectroCore Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Mainstay Medical
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms

欧州の神経刺激装置：2030年市場予測-地域別分析-製品、用途、エンドユーザー別

Europe Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州の神経刺激装置市場- 主要産業力学

第5章神経刺激装置市場：欧州市場分析

第6章欧州の神経刺激装置市場：製品別

第7章欧州の神経刺激装置市場：用途別

第8章欧州の神経刺激装置市場：エンドユーザー別

第9章欧州の神経刺激装置市場：国別

第10章神経刺激装置市場-業界情勢

第11章企業プロファイル

第12章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

5. Neurostimulation Devices Market - Europe Market Analysis

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

10. Neurostimulation Devices Market-Industry Landscape

11. Company Profiles

12. Appendix

欧州の神経刺激装置：2030年市場予測-地域別分析-製品、用途、エンドユーザー別

Europe Neurostimulation Devices Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 欧州の神経刺激装置市場- 主要産業力学

第5章 神経刺激装置市場：欧州市場分析

第6章 欧州の神経刺激装置市場：製品別

第7章 欧州の神経刺激装置市場：用途別

第8章 欧州の神経刺激装置市場：エンドユーザー別

第9章 欧州の神経刺激装置市場：国別

第10章 神経刺激装置市場-業界情勢

第11章 企業プロファイル

第12章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

5. Neurostimulation Devices Market - Europe Market Analysis

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

10. Neurostimulation Devices Market-Industry Landscape

11. Company Profiles

12. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州の神経刺激装置市場- 主要産業力学

第5章神経刺激装置市場：欧州市場分析

第6章欧州の神経刺激装置市場：製品別

第7章欧州の神経刺激装置市場：用途別

第8章欧州の神経刺激装置市場：エンドユーザー別

第9章欧州の神経刺激装置市場：国別

第10章神経刺激装置市場-業界情勢

第11章企業プロファイル

第12章付録